Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Plus, news about Re­cur­sion, Nx­era, Vi­a­tris and Du­al­i­ty­Bio:

Paci­ra Bio­Sciences takes on GQ Bio: The non-opi­oid pain biotech is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.